P.I.D. : 256622 V.I.D.
: 1024055534 Registered On : 06-Oct-2024 10:42 AM
Name : Ms. Renuka Bohra Collected On : 06-Oct-2024 10:35 AM
Age/Gender : 49 Years / Female Reported On : 06-Oct-2024 11:29 AM
Client Id :
Ref. By : Self
BODY PROFILE (EXECUTIVE)
COMPLETE BLOOD COUNT
Test Result Unit Reference Range
Done On Automated Cell Counter (EDTA Whole Blood)
Erythrocyte Count (Impedence) : 4.38 million/c.m.m 3.8 - 4.8
Haemoglobin (Colorimetric) : 10.5 gms/dl 12 - 15
P.C.V. (Calculated) : 34.6 % 36 - 48
M.C.V. (Calculated) : 79.0 fl. 82 - 100
M.C.H. (Calculated) : 24.0 pg 27 - 32
M.C.H.C. (Calculated) : 30.3 % 31.5 - 34.5
Rdw-CV (Impedence) : 13.3 % 11.6 - 14
Leucocyte Count (Laser Flowcytometry) : 9880 /c.m.m. 4000 - 10000
Platelet Count (Impedence + Laser : 398000 /c.m.m. 150000 - 500000
Flowcytometry)
M.P.V. (Calculated) : 8.9 fl. 7.5 - 11.5
DIFF. W.B.C. COUNT % (Calculated absolute diff. count/c.m.m.) (Laser Flowcytometry)
Neutrophil Count : 59 % 50 - 62
Neutrophil Abs : 5829 /c.m.m. 2000 - 7000
Lymphocyte Count : 34 % 25 - 40
Lymphocyte Abs : 3359 /c.m.m. 1000 - 3000
Eosinophil Count : 2 % 0-4
Eosinophil Abs : 198 /c.m.m. 20 - 500
Monocyte Count : 5 % 3-9
Monocyte Abs : 494 /c.m.m. 200 - 1000
Basophil Count : 0 % 0-1
Basophil Abs : 0 /c.m.m. 0 - 100
Peripheral Smear Findings (Microscopy, Fields stain, Leishmans stain)
Erythrocytes Morphology : Hypochromia
Leucocytes Morphology : Normal
Platelets : Adequate
Parasites : Not Seen
Please use the P.I.D for all your future REF.
DR. PRADNYA CHAVAN
Reg.No : 2014/04/1860
MBBS,DPB
Page 1 of 13
Print By / Date : AUTO / 06-Oct-2024 05:25 PM This is an Electronically Authenticated Report.
P.I.D. : 256622 V.I.D. : 1024055534 Registered On : 06-Oct-2024 10:42 AM
Name : Ms. Renuka Bohra Collected On : 06-Oct-2024 10:35 AM
Age/Gender : 49 Years / Female Reported On : 06-Oct-2024 11:29 AM
Client Id :
Ref. By : Self
BODY PROFILE (EXECUTIVE)
ERYTHROCYTE SEDIMENTATION RATE
Test Result Unit Reference Range
ESR : 23 m.m. 3 - 20
Sample type: EDTA whole blood
Method: Red cell aggregation (Photometric).
This is a modified method for faster and more accurate estimation of ESR. Erythrocyte Sedimentation Rate is the rate at which
red blood cells in anti-coagulated whole blood descend in a standardized tube over a period of 1 hour.
ESR indicates the presence and intensity of an inflammatory process. It is never diagnostic of a specific diseae. It is also useful
to monitor the course or responseto treatment of certain diseases.
Increased levels are seen in a wide range of Infectious diseases (TB, bacterial infections etc), Myocardial Infarction, Rheumatic
conditions, pregnancy, hyper and hypothyroidism etc.
Decreased levels are seen in Congestive Cardiac failure, Cachexia and high or long term steroid use.
DR. PRADNYA CHAVAN
Reg.No : 2014/04/1860
MBBS,DPB
Page 2 of 13
Print By / Date : AUTO / 06-Oct-2024 05:25 PM This is an Electronically Authenticated Report.
P.I.D. : 256622 V.I.D. : 1024055534 Registered On : 06-Oct-2024 10:42 AM
Name : Ms. Renuka Bohra Collected On : 06-Oct-2024 10:35 AM
Age/Gender : 49 Years / Female Reported On : 06-Oct-2024 01:23 PM
Client Id :
Ref. By : Self
BODY PROFILE (EXECUTIVE)
Test Result Unit Reference Range
Urea, Serum : 14.40 mg/dl 0-42.6
Method : (GLDH-Urease)
Bun (Calculated) : 6.7 mg/dl Upto 20
Creatinine, Serum : 0.5 mg/dl Upto 1.2
Method : (Kinetic Jaffe Reaction)
EGFR (Mdrd) : 139.4 ml/min/1.73 Sqm
ELECTROLYTES & CALCIUM
Test Result Unit Reference Range
Total Calcium, serum : 9.11 mg/dl 8.6 - 10.2
Method : (NM-BAPTA)
METHOD: ISE
DR. PRADNYA CHAVAN
Reg.No : 2014/04/1860
MBBS,DPB
Certificate No. - MC-5970 Page 3 of 13
Print By / Date : AUTO / 06-Oct-2024 05:25 PM This is an Electronically Authenticated Report.
P.I.D. : 256622 V.I.D. : 1024055534 Registered On : 06-Oct-2024 10:42 AM
Name : Ms. Renuka Bohra Collected On : 06-Oct-2024 10:35 AM
Age/Gender : 49 Years / Female Reported On : 06-Oct-2024 01:23 PM
Client Id :
Ref. By : Self
BODY PROFILE (EXECUTIVE)
ELECTROLYTES & CALCIUM
Test Result Unit Reference Range
Sodium, Serum : 141 mEq/l 136 - 145
Method : (Indirect ISE)
Potassium, Serum : 4.8 mEq/l 3.5 - 5.1
Method : (Indirect ISE)
Chloride, Serum : 105 mEq/l 98 - 107
Method : (Indirect ISE)
Bicarbonate, Serum : 25.6 mmol/L 22 - 29
Method : (UV Kinetic)
Anion Gap, Serum : 15.2 mEq/l 12 - 20
Method : (Calculated)
Ionic Calcium, Serum : 4.97 mg/dl 4.6 - 5.3
Method : (Direct ISE)
METHOD: ISE
DR. PRADNYA CHAVAN
Reg.No : 2014/04/1860
MBBS,DPB
Page 4 of 13
Print By / Date : AUTO / 06-Oct-2024 05:25 PM This is an Electronically Authenticated Report.
P.I.D. : 256622 V.I.D. : 1024055534 Registered On : 06-Oct-2024 10:42 AM
Name : Ms. Renuka Bohra Collected On : 06-Oct-2024 10:35 AM
Age/Gender : 49 Years / Female Reported On : 06-Oct-2024 01:23 PM
Client Id :
Ref. By : Self
BODY PROFILE (EXECUTIVE)
Test Result Unit Reference Range
Uric Acid, Serum : 5.0 mg/dl 2.4 - 5.7
Method : (Uricase PAP)
Total Protein, Serum : 6.52 gm/dl 6.6 - 8.7
Method : (Biuret method)
Albumin, Serum : 3.96 gm/dl 3.5 - 5.2
Method : (BCG Method)
Globulin, Serum : 2.56 gm/dl 1.8 - 3.6
Method : (Calculated)
A/G Ratio, Serum : 1.55 1.2 - 2.5
Method : (Calculated)
Total Bilirubin, Serum : 0.2 mg/dl 0 - 1.2
Method : (Diazotization)
Direct Bilirubin, Serum : 0.1 mg/dl 0 - 0.3
Method : (Diazotization)
Indirect Bilirubin, Serum : 0.1 mg/dl 0 - 1.1
Method : (Calculated)
S.G.O.T, Serum : 30.5 U/L 0 - 35
Method : (IFCC with P5P)
S.G.P.T, Serum : 48.2 U/L 0 - 35
Method : (IFCC with P5P)
G.G.T.P., Serum : 25.9 U/L Upto 42
Method : (IFCC)
Alkaline Phosphatase, Serum : 106 U/L 35 - 105
Method : (IFCC)
Note:-
-Isolated elevation of Alkaline Phosphotase in elderly may be associated with osteoporosis.
DR. PRADNYA CHAVAN
Reg.No : 2014/04/1860
MBBS,DPB
Certificate No. - MC-5970 Page 5 of 13
Print By / Date : AUTO / 06-Oct-2024 05:25 PM This is an Electronically Authenticated Report.
P.I.D. : 256622 V.I.D. : 1024055534 Registered On : 06-Oct-2024 10:42 AM
Name : Ms. Renuka Bohra Collected On : 06-Oct-2024 10:35 AM
Age/Gender : 49 Years / Female Reported On : 06-Oct-2024 01:23 PM
Client Id :
Ref. By : Self
BODY PROFILE (EXECUTIVE)
Test Result Unit Reference Range
Fasting Plasma Glucose : 100 mg/dl Interpretation of Fasting blood glucose
Method : (Hexokinase) levels:
70 - 100 mg/dl: Normal
100 - 126 mg/dl: Impaired Fasting
glucose
>126 mg/dl (on more than one occasion):
Diabetes
Optimal FBS level for Diabetics: 70 -
130 mg/dl.
HbA1c STUDY
Test Result Unit Reference Range
HbA1c : 7.6 % Less than 5.7%: Non-Diabetic
Method : (HPLC) 5.7% to 6.4%: Pre-Diabetes
More than 6.4%: Diabetes
Calculated Mean Plasma Glucose : 171.4 mg/dl
Sample type: Whole Blood
Reference values to measure control of blood glucose:
Less than 7%: Very good control
7% to 8%: Fair control
More than 8%: Poor control
DR. PRADNYA CHAVAN
Reg.No : 2014/04/1860
MBBS,DPB
Certificate No. - MC-5970 Page 6 of 13
Print By / Date : AUTO / 06-Oct-2024 05:25 PM This is an Electronically Authenticated Report.
P.I.D. : 256622 V.I.D. : 1024055534 Registered On : 06-Oct-2024 10:42 AM
Name : Ms. Renuka Bohra Collected On : 06-Oct-2024 10:35 AM
Age/Gender : 49 Years / Female Reported On : 06-Oct-2024 01:23 PM
Client Id :
Ref. By : Self
BODY PROFILE (EXECUTIVE)
EXTENDED LIPID PROFILE
Test Result Unit Reference Range
T. Cholesterol, Serum : 219 mg/dl Desirable: Less than 200 mg%
Method : (CHOD-PAP) Borderline High: 200 to 239 mg%
High: More than 240mg%.
H.D.L. Cholesterol, Serum : 37 mg/dl Desirable: More than 60 mg%
Method : (Direct PEG) Low: Less than 40 mg%.
Non H.D.L Cholesterol : 182.0 mg/dl <130 mg/dL
Method : (Calculated)
L.D.L.Cholestrol, Serum : 145 mg/dl Optimal: Less than 100 mg%
Method : (Friedwalds calc) Near/above Optimal: 100 TO 129 mg%
Borderline High: 130 TO 159 mg%
High: 160 TO 189 mg%
Very High: More than 189 mg%.
LDL/HDL Chol Ratio : 3.92 mg/dl <2.5 mg/dL
V.L.D.L Cholesterol, Serum : 37.4 mg/dl Upto 30 mg%.
Method : (Calculated)
TC/Hdlc Ratio, Serum : 5.92 Upto 4.5.
Atherogenic Coefficient (Non- HDLc / : 4.92 Less than 3.0
HDLc Ratio)
Triglycerides, Serum : 187 mg/dl Normal: Less than 150 mg%
Method : (GPO PAP) Borderline High: 150 To 199 mg%
High: 200 To 499 mg%
Very High: More than 499 mg%.
Apolipoprotein A-1, Serum : 110.0 mg/dl 108 - 225
Method : (Immunoturbidimetry)
Apolipoprotein B, Serum : 105 mg/dl 60 - 141
Method : (Immunoturbidimetry)
Apolipoprotein A1/B Ratio : 1.0 0.8 or more
DR. PRADNYA CHAVAN
Reg.No : 2014/04/1860
MBBS,DPB
Certificate No. - MC-5970 Page 7 of 13
Print By / Date : AUTO / 06-Oct-2024 05:25 PM This is an Electronically Authenticated Report.
P.I.D. : 256622 V.I.D. : 1024055534 Registered On : 06-Oct-2024 10:42 AM
Name : Ms. Renuka Bohra Collected On : 06-Oct-2024 10:35 AM
Age/Gender : 49 Years / Female Reported On : 06-Oct-2024 01:23 PM
Client Id :
Ref. By : Self
BODY PROFILE (EXECUTIVE)
Test Result Unit Reference Range
C.P.K., Serum : 30.4 U/L 20 - 180
Method : (UV Kinetic)
DR. PRADNYA CHAVAN
Reg.No : 2014/04/1860
MBBS,DPB
Certificate No. - MC-5970 Page 8 of 13
Print By / Date : AUTO / 06-Oct-2024 05:25 PM This is an Electronically Authenticated Report.
P.I.D. : 256622 V.I.D. : 1024055534 Registered On : 06-Oct-2024 10:42 AM
Name : Ms. Renuka Bohra Collected On : 06-Oct-2024 10:35 AM
Age/Gender : 49 Years / Female Reported On : 06-Oct-2024 01:05 PM
Client Id :
Ref. By : Self
BODY PROFILE (EXECUTIVE)
IRON STUDY
Test Result Unit Reference Range
Total Iron, Serum : 56.4 ugm/dl 37 - 145
Method : (Ferrozine)
T.I.B.C., Serum : 371 ugm/dl 255 - 450
Method : (Iron + UIBC direct ferrozyme)
Transferrin Saturation, Serum : 15.2 % 20 - 50
Method : (Calculated)
Ref: Wallach~s Interpretation of Diagnostic Tests, 9th Ed.
Ref: Wallach~s Interpretation of Diagnostic Tests, 9th Ed.
25 (OH) Vit. D
Test Result Unit Reference Range
25 (Oh) Vit. D, Serum : 19.1 ng/ml Deficiency: Less than 10 ng/ml
Insufficiency: 10 to 30 ng/ml
Sufficiency: 30 to 100 ng/ml
Toxicity: More than 100 ng/ml
* More than 95% of 25(OH) Vitamin D (above measured value) corresponds to VITAMIN D3 value
*25 (OH) Vit D is the only test recommended by The Endocrine society for screening of Vitamin D deficiency
Method: CLIA
Hetrophilic antibodies in human serum can react with reagent immunoglobins, interfering with in vitro immunoassays.
Patients routinely exposed to animal serum products can be prone to this interference and anomalous results may be
observed.
Ref: 1) J Clin Endocrinol Metab, July 2011, 96(7):1911–1930. 2) VITAMIN D STATUS: Annalsofepidemiology Vol. 19,
No.2, February 2009: 73–78
DR. PRATIK JARIWALA
M.D. PATHOLOGY
MMC NO.:200402379
Certificate No. - MC-5970 Page 9 of 13
Print By / Date : AUTO / 06-Oct-2024 05:25 PM This is an Electronically Authenticated Report.
P.I.D. : 256622 V.I.D. : 1024055534 Registered On : 06-Oct-2024 10:42 AM
Name : Ms. Renuka Bohra Collected On : 06-Oct-2024 10:35 AM
Age/Gender : 49 Years / Female Reported On : 06-Oct-2024 01:05 PM
Client Id :
Ref. By : Self
THYROID STIMULATING HORMONE (Ultrasensitive)
Test Result Unit Reference Range
Thyroid Stimulating Hormone : 2.45 uIU/ml Non Pregnant: 0.27 - 4.204.
(Ultrasensitive), Serum
Method : (ECLIA) 4.20 to 10.0 is considered as a borderline
result and may be due to physiological
factors. Clinical correlation is suggested.
Pregnancy:1st Trimester:- 0.33 - 4.59
2nd Trimester:- 0.35 - 4.10
3rd Trimester:- 0.21 - 3.15
Method: ECLIA
Hetrophilic antibodies in human serum can react with reagent immunoglobins, interfering with in vitro
immunoassays. Patients routinely exposed to animal serum products can be prone to this interference and anomalous
results may be observed.
DR. PRATIK JARIWALA
M.D. PATHOLOGY
MMC NO.:200402379
Certificate No. - MC-5970 Page 10 of 13
Print By / Date : AUTO / 06-Oct-2024 05:25 PM This is an Electronically Authenticated Report.
P.I.D. : 256622 V.I.D. : 1024055534 Registered On : 06-Oct-2024 10:42 AM
Name : Ms. Renuka Bohra Collected On : 06-Oct-2024 10:35 AM
Age/Gender : 49 Years / Female Reported On : 06-Oct-2024 01:23 PM
Client Id :
Ref. By : Self
BODY PROFILE (EXECUTIVE)
VITAMIN B12
Test Result Unit Reference Range
Vitamin B12, Serum : 812.0 pg/ml 107 - 653
Method : (CLIA)
Method: CLIA
Heterophilic antibodies in human serum can react with reagent immunoglobins, interfering with in vitro
immunoassays. Patients routinely exposed to animal serum products can be prone to this interference and anomalous
results may be observed.
Please Note: Reference range for Vitamin B12 assay changed from 07/08/24
DR. PRADNYA CHAVAN
Reg.No : 2014/04/1860
MBBS,DPB
Page 11 of 13
Print By / Date : AUTO / 06-Oct-2024 05:25 PM This is an Electronically Authenticated Report.
P.I.D. : 256622 V.I.D. : 1024055534 Registered On : 06-Oct-2024 10:42 AM
Name : Ms. Renuka Bohra Collected On : 06-Oct-2024 10:35 AM
Age/Gender : 49 Years / Female Reported On : 06-Oct-2024 03:54 PM
Client Id :
Ref. By : Self
BODY PROFILE (EXECUTIVE)
Test Result Reference Range
High Sensitivity CRP, Serum : 14.4 Low Risk: Less than 1.0 mg/L
Method : (Immunoturbidimetry) Average Risk: 1.0 to 3.0 mg/L
High Risk: More than 3.0 mg/L
SERUM IgE (TOTAL)
Test Result Reference Range
IgE (Total), Serum : 148 Upto 100
Method : (ECLIA)
Method: ECLIA
Heterophilic antibodies in human serum can react with reagent immunoglobins, interfering with in vitro
immunoassays. Patients routinely exposed to animal serum products can be prone to this interference and anomalous
results may be observed.
COVID-19 ANTIBODIES
(Nucleocapsid)
Test Result Reference Range
Covid-19 Antibodies (FIA) : Positive [ 27.7 ] INDEX:
Method : (FIA) <1.0 NON REACTIVE
>1.0 REACTIVE
Sample type: Serum
1. Antibody tests for COVID 19 are for serosurveillance only and are not to be used for Diagnosis of COVID 19 infections.
2. In certain situations, serological assays will support clinical assessment when person who present late in their illnesses when
used in conjunction with viral detection tests.
3. Serology assays for COVID 19 can play an important role in understanding the transmission dynamic of the virus in the
general population and identifying groups at higher risk for infection.
4. Antibody tests help determine whether the individual being tested was previously infected-even if that person never showed
symptoms.
5. It is currently not clear whether a positive serologic test indicates immunity against SARS-CoV-2.
6. Negative test does not rule out infection or likelyhood of developing disease in the future. All precautions must be taken to
avoid future infections.
7. A patient can still be infectious even if the antibody test is positive.
*** END OF THE REPORT ***
DR. PRADNYA CHAVAN
Reg.No : 2014/04/1860
MBBS,DPB
Page 12 of 13
Print By / Date : AUTO / 06-Oct-2024 05:25 PM This is an Electronically Authenticated Report.
P.I.D. : 256622 V.I.D. : 1024055534 Registered On : 06-Oct-2024 10:42 AM
Name : Ms. Renuka Bohra Collected On : 06-Oct-2024 10:35 AM
Age/Gender : 49 Years / Female Reported On : 06-Oct-2024 03:54 PM
Client Id :
Ref. By : Self
Please use the P.I.D for all your future REF.
DR. PRADNYA CHAVAN
Reg.No : 2014/04/1860
MBBS,DPB
Page 13 of 13
Print By / Date : AUTO / 06-Oct-2024 05:25 PM This is an Electronically Authenticated Report.
